Thus, dissociation of the MYB:CBP/P300 complex by MYBMIM would be expected to reduce MYB-dependent occupancy and gene trans-activation at specific target genes responsible for aberrant leukemia cell growth and survival. The gene discussed is CREBBP; the disease is leukemia.